{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:09:43Z","timestamp":1792454983913,"version":"4.5.0"},"reference-count":13,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2024,3,29]]},"abstract":"<jats:p>In this edition of the Huntington\u2019s Disease Clinical Trials Update, we expand on the ongoing program from VICO Therapeutics and on the recently terminated VIBRANT-HD clinical trials. We also discuss updates from uniQure\u2019s AMT-130 program and PTC therapeutics\u2019 trial of PTC518 and list all currently registered and ongoing clinical trials in Huntington\u2019s disease.<\/jats:p>","DOI":"10.3233\/jhd-240017","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T12:50:08Z","timestamp":1710247808000},"page":"1-14","source":"Crossref","is-referenced-by-count":43,"title":["Huntington\u2019s Disease Clinical Trials Corner: March 2024"],"prefix":"10.1177","volume":"13","author":[{"given":"Carlos","family":"Estevez-Fraga","sequence":"first","affiliation":[{"name":"Huntington\u2019s Disease Centre, UCL Queen Square Institute of Neurology, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Tabrizi","sequence":"additional","affiliation":[{"name":"Huntington\u2019s Disease Centre, UCL Queen Square Institute of Neurology, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Wild","sequence":"additional","affiliation":[{"name":"Huntington\u2019s Disease Centre, UCL Queen Square Institute of Neurology, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JHD-240017_ref6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3233\/JHD-170262","article-title":"Clinical Trials Corner: September 2017","volume":"6","author":"Rodrigues","year":"2017","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-240017_ref7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/brain\/awz328","article-title":"Antisense oligonucleotide therapeutics in neurodegenerative diseases: The case of polyglutamine disorders","volume":"143","author":"Silva","year":"2020","journal-title":"Brain"},{"key":"10.3233\/JHD-240017_ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0171127","article-title":"The expanded CAG repeat in the huntingtin gene as target for therapeutic RNA modulation throughout the HD mouse brain","volume":"12","author":"Datson","year":"2017","journal-title":"PLoS One"},{"key":"10.3233\/JHD-240017_ref11","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/s41467-022-28653-6","article-title":"An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusion","volume":"13","author":"Keller","year":"2022","journal-title":"Nat Commun"},{"key":"10.3233\/JHD-240017_ref13","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMc2300400","article-title":"Tominersen in adults with manifest Huntington\u2019s disease","volume":"389","author":"McColgan","year":"2023","journal-title":"N Engl J Med"},{"key":"10.3233\/JHD-240017_ref14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3233\/JHD-229006","article-title":"Huntington\u2019s Disease Clinical Trials Corner: November","volume":"11","author":"Estevez-Fraga","year":"2022","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-240017_ref18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JHD-189001","article-title":"Huntington\u2019s Disease Clinical Trials Corner: February 2018","volume":"7","author":"Rodrigues","year":"2018","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-240017_ref19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3233\/JHD-189003","article-title":"Huntington\u2019s Disease Clinical Trials Corner: August 2018","volume":"7","author":"Rodrigues","year":"2018","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-240017_ref20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3233\/JHD-190001","article-title":"Huntington\u2019s Disease Clinical Trials Corner: January 2019","volume":"8","author":"Rodrigues","year":"2019","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-240017_ref21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3233\/JHD-199003","article-title":"Huntington\u2019s disease clinical trials corner: June 2019","volume":"8","author":"Rodrigues","year":"2019","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-240017_ref22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3233\/JHD-200002","article-title":"Huntington\u2019s Disease Clinical Trials Corner: April 2020","volume":"9","author":"Rodrigues","year":"2020","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-240017_ref23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3233\/JHD-229002","article-title":"Huntington\u2019s Disease Clinical Trials Corner: April 2022","volume":"11","author":"Estevez-Fraga","year":"2022","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-240017_ref24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3233\/JHD-239001","article-title":"Huntington\u2019s Disease Clinical Trials Corner: August 2023","volume":"12","author":"Estevez-Fraga","year":"2023","journal-title":"J Huntingtons Dis"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-240017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:56:22Z","timestamp":1777452982000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-240017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":13,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jhd-240017","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,29]]}}}